INHIBITION OF CONTACT PATHWAY ACTIVATION FOR THE TREATMENT OF NEUROINFLAMMATION

ANTI-PMEPA-1 ANTIBODIES OR ANTIGEN BINDING FRAGMENTS THEREOF, COMPOSITIONS, AND USES THEREOF

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

ACE2-Targeted Compositions and Methods for Treating COVID-19

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

METHODS OF TREATING CD20 EXPRESSING B-CELL CANCERS

ANTI-OX40 ANTIBODIES AND METHODS OF USE

DR5-TARGETING MULTABODIES FOR THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS

ANTI IL-36R ANTIBODIES

METHODS FOR THE TREATMENT AND PREVENTION OF GPP

Binding Molecules Targeting IL-2 Receptor

ANTI-NMDAR2B ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE

INHIBITORS FOR USE IN PREVENTION- AND/OR ALLEVIATION OF HEART FIBROSIS

AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1

SERUM HALF-LIFE EXTENDED PD-L1 BINDING POLYPEPTIDES

ANTI-CD8 ANTIBODIES AND USES THEREOF

MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF

MULTISPECIFIC ANTIBODIES AND USES THEREOF

Methods and Compositions for Preventing Type 1 Diabetes

HUMANIZED ANTIBODIES AGAINST NECTIN-2 AND DRUG CONJUGATES THEREOF

AQUEOUS FORMULATIONS OF AN ANTI-CD22 ANTIBODY AND USES THEREOF

INHIBIN ANTIBODIES AND CANCER TREATMENT

ANTIBODY FOR RECOGNIZING RSV PRE-F PROTEIN AND USE THEREOF

COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES

DUAL CYTOKINE FUSION PROTEINS COMPRISING MULTI-SUBUNIT CYTOKINES

METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

Muscle targeting complexes and uses thereof for treating dystrophinopathies

IMMUNOCONJUGATES AND METHODS

Immunoconjugates and methods

METHODS AND COMPOSITIONS FOR TREATING CANCER

MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES

IONIC LIQUIDS FOR DRUG DELIVERY

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS

ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1, ANTI-PD-L1 OR ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF CANCER

DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS

NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN IMMUNOMODULATOR AND CHEMOTHERAPEUTIC DRUGS FOR INHIBITION OF CANCER

DYNAMIC I/O VIRTUALIZATION SYSTEM HAVING GUEST MEMORY MANAGEMENT FOR MAPPING VIRTUAL ADDRESSES USING VIRTUALIZATION APPLICATION PROGRAMMING INTERFACE (API) IN GUEST KERNAL

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER

MND PROMOTER CHIMERIC ANTIGEN RECEPTORS

USES OF DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES

ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF

Antibody Binding to CHI3L1 for Treating Cancer

MULTISPECIFIC ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS

CD38 MONOCLONAL ANTIBODY AND APPLICATION THEREOF

Variant nucleic acid libraries for coronavirus

SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

COMBINATION OF ANTI-CD40 ANTIBODY AND IL-15 FOR TREATING CANCER

OPTIMIZED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

ANTI-IFNAR1 DOSING REGIME FOR SUBCUTANEOUS INJECTION

COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES

CD47/PD-L1-TARGETING PROTEIN COMPLEX AND METHODS OF USE THEREOF

NOVEL ANTI-CD276 ANTIBODIES AND THE USES THEREOF

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

MULTIFUNCTIONAL ANTIBODY-LIGAND TRAPS TO COUNTERACT IMMUNE TOLERANCE

BISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THERAPEUTIC USES THEREOF

METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY

ANTIBODIES FOR SIGLEC-15 AND METHODS OF USE THEREOF TO TREAT DISUSE OSTEOPOROSIS

SIRP GAMMA ANTIBODIES AND USES THEREOF

CLAUDIN 4 AND CLAUDIN 9 ANTIBODIES AND METHODS OF TREATING CANCER

MONOCONAL ANTIBODIES TO IL-25 AND USES THEREOF

ANTI-IL23 ANTIBODY FUSION PROTEIN AND USES THEREOF

METHODS FOR TREATING ATOPIC DERMATITIS AND RELATED DISORDERS

NON-HUMAN MAMMALIAN MODEL EXPRESSING IL-8 AND USE THEREOF

THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF USE

Anti-Sclerostin Antibodies and Their Use to Treat Bone Disorders as Part of a Regimen

ANTI-PERIOSTIN HUMANIZED MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTIBODIES TARGETING C5AR

ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF

ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION IN PEDIATRIC SUBJECTS

NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST COVID-19

Anti-HBsAg antibody for treatment of chronic hepatitis D

April and BAFF inhibitory immunomodulatory proteins and methods of use thereof

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF

Muscle targeting complexes and uses thereof for treating dystrophinopathies

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER

METHODS OF TREATING CANCER AND THE PHARMACEUTICAL COMPOSITIONS THEREOF

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR

ENGINEERED RECEPTORS AND MONOCLONAL ANTIBODIES FOR CRONAVIRUSES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING MALIGNANT, AUTOIMMUNE AND INFLAMMATORY DISEASES

METHODS OF TREATING CANCER

ANTI-LAG3 BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE

ANTI-C5 ANTIBODIES COMBINATIONS AND USES THEREOF

ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS

MOLECULES THAT BIND TO NEUTROPHIL ELASTASE POLYPEPTIDES

AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF

ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS

ANTIBODIES

Humanized complement 5a receptor 1 antibodies and methods of use thereof

COMPOSITIONS COMPRISING A BISPECIFIC GPRC5D/CD3 ANTIBODY

AGONISTIC CD40 ANTIBODIES AS IMMUNE STIMULATORY AGENTS

ANTI-CD30 ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR COMPRISING THEREOF

TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIES

ANTIGEN-BINDING MOLECULE

ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF NEUTROPHILIC DERMATOSES

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

LONG-ACTING ANTI-CCR5 BINDING AGENTS FOR THE PREVENTION AND TREATMENT OF HIV

AAV-MEDIATED EXPRESSION OF LONG-ACTING ANTI-CCR5 BINDING AGENTS FOR THE TREATMENT AND PREVENTION OF HIV

IL1RAP ANTIBODIES AND USES THEREOF

HETERODIMERIC PROTEIN AND APPLICATION THEREOF

IMMUNOMODULATORY MOLECULES AND USES THEREOF

ANTI-ROR ANTIBODY CONSTRUCTS

METHODS OF TREATING CANCERS ASSOCIATED WITH IMMUNOSUPPRESSIVE B CELLS

TREATMENT WITH ANTI-KIR3DL2 AGENTS

ANTI-TIM-3 ANTIGEN ANTIBODY OR ANTIBODY DERIVATIVE, AND USE THEREOF

ANTI-GROWTH HORMONE ANTIBODY

ANTI-IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN BOWEL URGENCY IN ULCERATIVE COLITIS

METHODS AND COMPOSITIONS FOR TREATING PLAQUE PSORIASIS

ANTIBODIES TARGETING XCL1 AND METHODS OF USING THE SAME

MODULATION OF WNT SIGNALLING IN PULMONARY DISORDERS

BI-FUNCTIONAL FUSION PROTEIN AND USES THEREOF

METHODS FOR INHIBITING MYOSTATIN ACTIVATION BY ADMINISTERING ANTI-PRO/LATENT MYOSTATIN ANTIBODIES

Tau binding compounds

METHOD OF TREATING BONE CANCERS

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

HEPATITIS B VIRUS ANTIVIRUS (HBV-ANTIVIRUS) COMPOSITIONS AND METHODS OF USE

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

Respiratory syncytial virus (RSV) vaccine

RADIOLABELING OF POLYPEPTIDES

Gene-regulating compositions and methods for improved immunotherapy

METHODS OF INCREASING STRENGTH AND FUNCTIONALITY WITH GDF8 INHIBITORS

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

GENETICALLY MODIFIED MOUSE THAT EXPRESSES HUMANIZED PD1 AND PD-L1 PROTEINS

METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS

IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS

ANTI-NGLY-1 ANTIBODIES AND METHODS OF USE

Anti-Jagged1 Antibodies and Methods of Use

CD5L-BINDING ANTIBODIES AND USES FOR THE SAME

ANTI-OX40 ANTIBODIES AND METHODS OF USE

ANTI-CD40 ANTIBODY AND USE THEREOF

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE

Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof

BISPECIFIC BINDING PROTEINS THAT BIND CD137 AND A TUMOR ASSOCIATED ANTIGEN

BISPECIFIC ANTIBODY AND APPLICATION THEREOF

METHODS OF TREATING TAU PATHOLOGIES

ANTI-O1 ANTIBODIES AND USES THEREOF

FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA

INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER

Composition Comprising HDAC Inhibitor and Immune Checkpoin Inhibitor and Methods For Using the Same

Immunomodulating treatments of body cavities

COMPOSITION COMPRISING PD-L1 ANTIGEN-BINDING FRAGMENT AND USE THEREOF

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

Multivalent and Multispecific DR5-Binding Fusion Proteins

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

IL23R BINDING MOLECULES AND METHODS OF USE

ANTI-C-MET ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES

VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE

TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE

PROTEIN SPECIFICALLY BINDING TO PD-1 AND PHARMACEUTICAL USE THEREOF

ANTIBODIES SPECIFIC TO HUMAN NECTIN4

Improved Antibody Masking Domains

CD112 ANTIBODY AND USE

ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF USE

HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN

ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2

TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN

NOVEL COMBINATIONS OF ANTIBODIES AND USES THEREOF

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSE

HERV-K ANTIBODY THERAPEUTICS

AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS

ADVANCED MODELING FOR BIOLOGICS

ANTIGEN CD111 AS A NEW SPECIFIC DIAGNOSTIC AND THERAPEUTIC MARKER FOR POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS (PMN-MDSCS)

METHODS FOR TREATING PATIENTS WITH AN AUTOANTIBODY-MEDIATED DISEASE

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR

ANTI-TRANSFERRIN RECEPTOR ANTIBODY-PMO CONJUGATES FOR INDUCING DMD EXON 44 SKIPPING

ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF

MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ANTIBODIES AGAINST GPC3 AND USES THEREOF

Anti-human CD73 monoclonal antibody without hook effect

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ST2 ANTIGEN BINDING PROTEINS

ANTI-ACVR2A ANTIBODIES AND USES THEREOF

BISPECIFIC ANTI-FLT3/CD3 ANTIBODIES AND METHODS OF USE

ANTI-GFRAL ANTIBODY AND APPLICATION THEREOF

MICA ANTIBODY WITH AFFINITY MATURATION AND USE THEREOF

A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

SIRP1a TARGETED CHIMERIC PROTEINS AND USES THEREOF

ANTI-NECTIN4 ANTIBODIES AND MULTI-SPECIFIC PROTEIN COMPLEXES COMPRISING SUCH

MULTISPECIFIC HEAVY CHAIN ANTIBODIES BINDING TO CD22 AND CD3

COMPOSITIONS AND METHODS FOR TREATING LONG QT SYNDROME

ANTI-FOLR1 IMMUNOCONJUGATE REGIMENS

METHOD OF MODULATING THE ACTIVITY OF ADRENOMEDULLIN IN A SUBJECT IN NEED OF THERAPEUTIC INTERVENTION FOR ORGAN DYSFUNCTION OR ORGAN FAILURE ASSOCIATED WITH ADRENOMEDULLIN (ADM) ACTIVITY BY ADMINISTERING AN ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR AN ANTI-ADM FRAGMENT TO THE SUBJECT

IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF

Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody

OPTIMIZED ANTI-TL1A ANTIBODIES

A MYOSTATIN PATHWAY INHIBITOR IN COMBINATION WITH A GLP-1 PATHWAY ACTIVATOR FOR USE IN TREATING METABOLIC DISORDERS

HUMANIZED ANTI-HUMAN ßIG-H3 PROTEIN AND USES THEREOF

GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78

COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY

Antibodies to Andes Hantavirus, and Methods for Using Same

ACCELERATED METHOD OF MAKING LYOPHILIZED PROTEIN FORMUALTIONS

GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS

CHIMERIC ENGULFMENT RECEPTOR MOLECULES

TREATMENT OF BLADDER CANCER WITH RADIOLABELED ANTIBODIES TARGETING CDCP1

SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS

ANTI-NECTIN-4 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTI-FOLATE RECEPTOR CONJUGATE COMBINATION THERAPY WITH BEVACIZUMAB

CLAUDIN 18.2 T CELL-ANTIGEN COUPLERS AND USES THEREOF

FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS

COMBINATIONS AND USES THEREOF

COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT

PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES THEREOF FOR THE TREATMENT OF CANCERS

Methods of Treating Neurologic Disorders

MULTIDOSE ANTIBODY DRUG PRODUCTS USING PHENOL OR BENZYL ALCOHOL

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

ANTI-GARP ANTIBODY

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

HUMANIZED ANTIBODIES THAT BIND LGR5

ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1

Therapeutic Anti-CD9 Antibody

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

METHODS FOR TARGETED IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML)

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

ANTI-TSLPR (CRLF2) ANTIBODIES

METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ADMINISTERING AN IL-4R ANTAGONIST

DOSE

ANTIBODY MOLECULES AND CONJUGATES

ANTIBODY

ANTI-PD-L1 AND IL-2 CYTOKINES

ANTI-CD19 ANTIBODY IN THE TREATMENT OF CNS LYMPHOMA

LILRB1 and LILRB2 ANTIBODIES AND METHODS OF USE THEREOF

Safe and Effective Method of Treating Psoriasis with Anti-IL23 Specific Antibody

TREATMENT OF FIBROSIS

USE OF AN IL-18 ANTAGONIST FOR TREATING AND/OR PREVENTION OF ATOPIC DERMATITIS OR A RELATED CONDITION

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

Antigen Binding Molecules Targeting SARS-CoV-2

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

IMMUNOCONJUGATE MOLECULES AND RELATED METHODS AND COMPOSITIONS THEREOF

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION

USE OF NOX INHIBITORS FOR TREATMENT OF CANCER

NANOPARTICLES FOR CANCER TREATMENT

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

Methods for Diagnosing and Treating Ischemic Eye Disease

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY

ANTIBODIES TARGETING IMMUNOSUPPRESSIVE B CELLS

METHODS FOR INHIBITING ANGIOGENESIS IN A SUBJECT IN NEED THEREOF

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH

ANTI-CD73 ANTIBODIES AND USES THEREOF

ANTI-OX40 ANTIBODIES AND USES THEREOF

METHODS FOR TREATING MULTIPLE MYELOMA

METHODS FOR THE TREATMENT OF GPP

Anti-CCR8 Antibodies and Uses Thereof

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO HGFR AND EGFR, AND PHARMACEUTICAL USE THEREOF

METHODS OF TREATING EYE DISEASE

PEPTIDE-CENTRIC CHIMERIC ANTIGEN RECEPTORS TO CANCER SELF-PEPTIDES

ANTIBODIES AND VARIANTS THEREOF AGAINST HUMAN CD16a

A PHARMACEUTICAL FORMULATION OF IMMUNE CHECK POINT INHIBITORS

Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind CD3 and CD20, and Uses Thereof

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

USE OF M-CSF OR G-CSF FOR DIAGNOSIS OR TREATMENT OF PULMONARY FIBROSIS

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

PHARMACEUTICAL COMPOSITION OF ANTI-ANGPTL3 ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF AND ITS APPLICATION

C-TERMINAL ANTIBODY VARIANTS

SUBCUTANEOUS FORMULATIONS OF ANTI-ABETA PROTOFIBRIL ANTIBODY AND METHODS OF USE THEREOF

ANTIBODY DRUG FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES

ANTI-CGRP ANTIBODY DOSING AND SCREENING METHODS

COMPOSITIONS FOR TREATING TAUOPATHIES AND METHODS OF USE THEREOF

Inhibitors of complement factor H

ANTIBODIES AGAINST CANDIDA ALBICANS PROTEINS AND THEIR THERAPEUTIC AND PROPHYLACTIC USE FOR TREATING AND PREVENTING INVASIVE FUNGAL INFECTIONS

NEUTRALIZING ANTIBODY FOR FLAVIVIRUSES AND PRODUCTION METHOD THEREOF

GENE SEQUENCE CONSTRUCT FOR GENE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HERPES SIMPLEX VIRUS INFECTION

SYSTEMS AND METHODS FOR NUCLEIC ACID EXPRESSION IN VIVO

MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE

METHODS FOR TREATING EOSINOPHILIC GASTROENTERITIS BY ADMINISTERING AN IL-4R ANTAGONIST

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

Antibody-drug conjugates and uses thereof

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

RESPONSE TO EGFR BLOCKADE

RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME

Compositions and Methods for Targeting Cancer Stem Cells

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

ANTI-PLASMA KALLIKREIN ANTIBODY DOSING REGIMENS FOR TREATING HEREDITARY ANGIOEDEMA

Bispecific T cell Engagers

Compositions and Methods for Targeting Cancer Stem Cells

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS